Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Xiaoni Guan"'
Publikováno v:
Schizophrenia, Vol 10, Iss 1, Pp 1-5 (2024)
Abstract Patients with schizophrenia (SCZ) smoke up to three times more than general people. However, there are conflicting results regarding the relationship between tobacco smoke and clinical symptom severity in SCZ. The aim of this study was to as
Externí odkaz:
https://doaj.org/article/2259989989df4c62b117e59c2cb16e49
Publikováno v:
Schizophrenia, Vol 10, Iss 1, Pp 1-5 (2024)
Abstract Innate immunity has been shown to be associated with schizophrenia (Sch). This study explored the relationship between symptoms and neutrophil-to-lymphocyte ratio (NLR) (a marker of innate immunity) in patients with Sch. Ninety-seven first-e
Externí odkaz:
https://doaj.org/article/a18d385b16734040b86d4d0b86b4b3ad
Publikováno v:
Schizophrenia, Vol 9, Iss 1, Pp 1-6 (2023)
Abstract High frequency (HF)-rTMS has been shown to improve cognitive functions in patients with schizophrenia (SCZ). This study aimed to investigate whether COX-2 rs5275 variants were associated with cognitive improvements following rTMS treatment i
Externí odkaz:
https://doaj.org/article/a3baeaeeb6544e808e94809554448585
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: There is sufficient evidence of the high prevalence of obesity in schizophrenia (SZ) compared to the general population. Previous studies have reported that weight gain correlated with the response to antipsychotics in patients with SZ. N
Externí odkaz:
https://doaj.org/article/18f3bda1ce864134a49dc53c4998c1a9
Publikováno v:
Schizophrenia, Vol 10, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/1845f153c7f8402ab1108de3fa993013
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Brain-derived neurotrophic factor (BDNF) is reported to be involved in cognitive decline in patients with schizophrenia (SZ). Previous studies have found that cognitive deficits remain stable during the chronic disease phase in SZ, but the f
Externí odkaz:
https://doaj.org/article/6a05cba8e94c4e2089138ecc119d8f9e
Publikováno v:
Translational Psychiatry, Vol 11, Iss 1, Pp 1-5 (2021)
Abstract A growing number of studies have shown that brain-derived neurotrophic factor (BDNF) is associated with weight gain during antipsychotic treatment in schizophrenia patients. However, there is still a lack of research results in the initial s
Externí odkaz:
https://doaj.org/article/6a01ed26fc8d4c2394851d431b56b304
Publikováno v:
CNS Neuroscience & Therapeutics. 28:1539-1546
A metabolomics approach has recently been used to identify metabolites associated with response to antipsychotic treatment. This study was designed to identify the predictive biomarkers of response to olanzapine monotherapy using a metabolomics-based
Autor:
Cheng Zhu, Xiaoni Guan, Yuechan Wang, Jiahong Liu, Thomas R. Kosten, Meihong Xiu, Fengchun Wu, Xiangyang Zhang
Publikováno v:
Neurotherapeutics
Many patients with schizophrenia (SCZ) discontinue antipsychotics, frequently due to dose-related multiple and severe adverse effects. We hypothesized that a low-dose ziprasidone plus sertraline would reduce serious side effects without affecting tre
Background Cognitive deficits are a core symptom of schizophrenia (SCZ). Lysophosphatidylethanolamine (LysoPE) has been reported to be involved in cognitive decline, but no studies have investigated its role in cognitive impairment in SCZ. The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92f5a19a820c8eef2ed3ed6c3a0e1fbb
https://doi.org/10.21203/rs.3.rs-2339101/v1
https://doi.org/10.21203/rs.3.rs-2339101/v1